Claire E. Knezevic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claire E. Knezevic has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Ashley R Rackow
Department of Pathology, Division of Clinical Chemistry, Johns Hopkins University, Baltimore, MD, United States
2 shared publicationsKyana Y. Garza
Department of Pathology, Johns Hopkins University, 1800 Orleans St., Sheikh Zayed Tower, B1020-G, Baltimore, MD 21287, USA
2 shared publicationsAaron Mahomes
Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA
1 shared publicationAashish Pandey
Department of Medicine, Johns Hopkins University, Bayview Medical Center, 4940 Eastern Ave, Mason F. Lord Tower, Suite 6000, Room 607, Baltimore, MD 21224, USA
1 shared publication- Aashish Pandey
University of North Texas, United States of America
1 shared publication Ahmet Baschat
Department of Gynecology and Obstetrics, Johns Hopkins University , Baltimore, MD , USA
1 shared publication
Latest Publications
- 17 December 2024
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
Effect of Hemolysis on Routine Blood Gas and Whole Blood Analytes
Background: Hemolysis is a major pre-analytical concern for many laboratory analytes; however, instruments utilized for whole blood chemistries and blood gas measurements lack the ability to detect and measure the degree of hemolysis. This study evaluated the effect of hemolysis on 13 routine whole blood and blood gas analytes and compared visual assessments of hemolysis to measured hemolysis (H-index). Methods: Remnant whole blood samples (n = 85) were split into 2 portions and aspirated through a syringe one or more times. To induce hemolysis, a needle was affixed to the end of the syringe to provide shear stress, and a mock procedure without syringe was used as a control. Samples were analyzed on a Radiometer ABL800 series instrument, centrifuged, and the H-index of the plasma portion was measured. Two medical technologists recorded a visual categorization of the specimens as slightly, moderately, or severely hemolyzed. Results: Hemolysis had a modest effect on metabolites and most cooximetry components, with percent bias within ±5% at all levels of hemolysis. Methemoglobin exhibited a larger overall negative bias, up to 13.3%. The absolute pH bias was fairly consistent (within 0.1 pH units) across all levels of hemolysis. As expected, potassium displayed a significant positive bias with increasing hemolysis. Sodium and ionized calcium displayed overall linear trends with a significant negative bias. Conclusions: Hemolysis can falsely increase or decrease certain blood gas analytes and lead to misinterpretation of results. Therefore, hemolysis detection capabilities are crucial for mitigating this effect and ensuring accurate results for patient care.
- 17 December 2024
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
Effect of Hemolysis on Routine Blood Gas and Whole Blood Analytes
Background: Hemolysis is a major pre-analytical concern for many laboratory analytes; however, instruments utilized for whole blood chemistries and blood gas measurements lack the ability to detect and measure the degree of hemolysis. This study evaluated the effect of hemolysis on 13 routine whole blood and blood gas analytes and compared visual assessments of hemolysis to measured hemolysis (H-index). Methods: Remnant whole blood samples (n = 85) were split into 2 portions and aspirated through a syringe one or more times. To induce hemolysis, a needle was affixed to the end of the syringe to provide shear stress, and a mock procedure without syringe was used as a control. Samples were analyzed on a Radiometer ABL800 series instrument, centrifuged, and the H-index of the plasma portion was measured. Two medical technologists recorded a visual categorization of the specimens as slightly, moderately, or severely hemolyzed. Results: Hemolysis had a modest effect on metabolites and most cooximetry components, with percent bias within ±5% at all levels of hemolysis. Methemoglobin exhibited a larger overall negative bias, up to 13.3%. The absolute pH bias was fairly consistent (within 0.1 pH units) across all levels of hemolysis. As expected, potassium displayed a significant positive bias with increasing hemolysis. Sodium and ionized calcium displayed overall linear trends with a significant negative bias. Conclusions: Hemolysis can falsely increase or decrease certain blood gas analytes and lead to misinterpretation of results. Therefore, hemolysis detection capabilities are crucial for mitigating this effect and ensuring accurate results for patient care.
- 29 October 2024
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 70 (12) , 1416-1419
Progressive Motor Regression in a 3-Year-Old: Dietary Trends Revive an Overlooked Diagnosis
- 29 October 2024
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 70 (12) , 1416-1419
Progressive Motor Regression in a 3-Year-Old: Dietary Trends Revive an Overlooked Diagnosis
- 26 July 2024
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 163 (1) , 69-79
Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals
Objectives: Urine drug testing (UDT) is a critical tool used in medical, forensic, and occupational settings, but interpreting results can be challenging. We performed a study to assess the ability of health care professionals to interpret UDT results accurately. Methods: In total, 911 clinical and laboratory professionals in the United States and Canada responded to a survey with questions gauging expertise in UDT interpretation. Responses were analyzed to identify knowledge gaps. Results: Toxicologists and laboratory PhD scientists performed well, with means of 4.82 and 4.63 questions answered correctly (out of 6 possible), respectively. Physicians specializing in pathology, emergency medicine, primary care, and internal medicine, however, displayed concerning knowledge gaps, as did laboratorians with nondoctoral degrees. Experience and training correlated with interpretation accuracy. Identification of simulated compliance as well as understanding opioid exposure, metabolism, and immunoassay cross-reactivity were among the most clinically significant knowledge gaps. More than 30% of survey respondents indicated that they would seek UDT information from the internet or peers rather than clinical or laboratory experts. Conclusions: The study highlighted the need for targeted education and better collaboration between clinical and laboratory experts and other health care professionals to ensure that when physicians order UDT, they can accurately interpret results and reduce harm.
- 26 July 2024
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 163 (1) , 69-79
Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals
Objectives: Urine drug testing (UDT) is a critical tool used in medical, forensic, and occupational settings, but interpreting results can be challenging. We performed a study to assess the ability of health care professionals to interpret UDT results accurately. Methods: In total, 911 clinical and laboratory professionals in the United States and Canada responded to a survey with questions gauging expertise in UDT interpretation. Responses were analyzed to identify knowledge gaps. Results: Toxicologists and laboratory PhD scientists performed well, with means of 4.82 and 4.63 questions answered correctly (out of 6 possible), respectively. Physicians specializing in pathology, emergency medicine, primary care, and internal medicine, however, displayed concerning knowledge gaps, as did laboratorians with nondoctoral degrees. Experience and training correlated with interpretation accuracy. Identification of simulated compliance as well as understanding opioid exposure, metabolism, and immunoassay cross-reactivity were among the most clinically significant knowledge gaps. More than 30% of survey respondents indicated that they would seek UDT information from the internet or peers rather than clinical or laboratory experts. Conclusions: The study highlighted the need for targeted education and better collaboration between clinical and laboratory experts and other health care professionals to ensure that when physicians order UDT, they can accurately interpret results and reduce harm.
- 7 March 2024
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 243, 116082
Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry
- 7 March 2024
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 243, 116082
Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry
- 4 December 2023
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 48 (2) , 126-129
Solriamfetol and m-chlorophenylpiperazine cause false positive amphetamine results on urine drug screening
Urine drug screening by immunoassay is a common method to quickly identify drug exposures in the emergency setting and to detect unexpected drug exposures in a variety of patient care and occupational health settings. Although they provide rapid results, immunoassays are susceptible to cross-reactivity with other medications and metabolites. Herein we evaluate the performance of the Thermo Scientific DRI Amphetamines immunoassay for reactivity with trazodone, aripiprazole, atomoxetine, solriamfetol and relevant metabolites. Each of these compounds were spiked into drug-free urine across a range of concentrations and assessed for positivity on amphetamine screen. We demonstrate that the Thermo Scientific DRI assay is susceptible to interferences from m-chlorophenylpiperazine (mCPP), the main metabolite of trazodone, and solriamfetol. Characterization of assay-specific interferences in toxicology screening is instrumental for accurate interpretation of toxicology results, evaluation of patients in emergent settings and supporting patient care.
- 4 December 2023
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 48 (2) , 126-129
Solriamfetol and m-chlorophenylpiperazine cause false positive amphetamine results on urine drug screening
Urine drug screening by immunoassay is a common method to quickly identify drug exposures in the emergency setting and to detect unexpected drug exposures in a variety of patient care and occupational health settings. Although they provide rapid results, immunoassays are susceptible to cross-reactivity with other medications and metabolites. Herein we evaluate the performance of the Thermo Scientific DRI Amphetamines immunoassay for reactivity with trazodone, aripiprazole, atomoxetine, solriamfetol and relevant metabolites. Each of these compounds were spiked into drug-free urine across a range of concentrations and assessed for positivity on amphetamine screen. We demonstrate that the Thermo Scientific DRI assay is susceptible to interferences from m-chlorophenylpiperazine (mCPP), the main metabolite of trazodone, and solriamfetol. Characterization of assay-specific interferences in toxicology screening is instrumental for accurate interpretation of toxicology results, evaluation of patients in emergent settings and supporting patient care.
- Open Access
- 1 April 2023
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 28, 9-12
A persistently febrile patient post-bone marrow transplant
- 1 April 2023
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 28, 9-12
Open AccessA persistently febrile patient post-bone marrow transplant
- Open Access
- 27 October 2022
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 68 (12) , 1486-1492
Rising to the Challenge: Shortages in Laboratory Medicine
At the beginning of the SARS-CoV-2 pandemic, one immediate impact on everyone’s day-to-day lives was the sudden shortage of essential consumable goods, such as soap, hand sanitizer, toilet paper, and shelf-stable foods. As regions implemented lockdowns, workplaces reduced staff density to maintain social distancing, countries employed travel restrictions, and the production and shipping of goods decreased. This caused mass shortages in the workforce, which were further compounded by existing staff becoming sick and the older workforce choosing to retire early. Healthcare, where ubiquitous disposable items provide safety and consistency to nearly every task, was not immune to this phenomenon. Healthcare providers suffered shortages of critical items such as gloves, masks, collection kits/containers, pipette tips, reagent packs, and disinfectants at variable time intervals as successive waves of the pandemic rolled across the globe.
- 27 October 2022
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 68 (12) , 1486-1492
Open AccessRising to the Challenge: Shortages in Laboratory Medicine
At the beginning of the SARS-CoV-2 pandemic, one immediate impact on everyone’s day-to-day lives was the sudden shortage of essential consumable goods, such as soap, hand sanitizer, toilet paper, and shelf-stable foods. As regions implemented lockdowns, workplaces reduced staff density to maintain social distancing, countries employed travel restrictions, and the production and shipping of goods decreased. This caused mass shortages in the workforce, which were further compounded by existing staff becoming sick and the older workforce choosing to retire early. Healthcare, where ubiquitous disposable items provide safety and consistency to nearly every task, was not immune to this phenomenon. Healthcare providers suffered shortages of critical items such as gloves, masks, collection kits/containers, pipette tips, reagent packs, and disinfectants at variable time intervals as successive waves of the pandemic rolled across the globe.
- 23 August 2022
- Published by Elsevier in Clinical Biochemistry
- Vol. 115, 81-85
Evaluation of serum and rapid serum separator collection tubes for therapeutic drug assays
- 23 August 2022
- Published by Elsevier in Clinical Biochemistry
- Vol. 115, 81-85
Evaluation of serum and rapid serum separator collection tubes for therapeutic drug assays
- 16 June 2022
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 7 (5) , 1158-1163
Improvement of Umbilical Cord Blood Gas Analysis with Implementation of Clot Catchers
Background: Umbilical cord blood gas testing is a key component of objective pre- and perinatal evaluation of fetal acid base status to determine presence of intrapartum asphyxia and risk of neonatal encephalopathy. Heparinized cord blood is more likely to form small clots than other blood sources, which can interfere with, or preclude, sample analysis. Cord blood samples are irreplaceable and cannot be recollected, thereby compromising clinical decision-making when analysis is not possible. We evaluated processes to prevent excessive rates of cord blood clotting and quantified their impact on successful testing of blood gas specimens. Methods: Verified result and cancellation data were obtained retrospectively from the laboratory information system. Clot catchers were evaluated using noncord remnant specimens. Collection syringes were compared via collection from remnant cord sections. Results: Prior to implementation of any interventions, retrospective analysis indicated a cancellation rate of 18.6% for umbilical cord blood gas specimens (arterial and venous) and 0.7% for noncord blood arterial and venous samples. Clot catchers were validated for clinical use, with a bias of <±4% for all analytes. After clot catchers were implemented for all cord specimens, cancellation rate decreased approximately 5-fold in the first month and remained <5% a year after implementation. A limited comparison of two heparin syringe types revealed a small difference in the overall rate of specimen clotting. Conclusions: Implementation of clot catchers was acceptable for analysis of cord blood samples, and when implemented resulted in a sustained 5-fold decrease in the rate of cord blood gas order cancellation.
- 16 June 2022
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 7 (5) , 1158-1163
Improvement of Umbilical Cord Blood Gas Analysis with Implementation of Clot Catchers
Background: Umbilical cord blood gas testing is a key component of objective pre- and perinatal evaluation of fetal acid base status to determine presence of intrapartum asphyxia and risk of neonatal encephalopathy. Heparinized cord blood is more likely to form small clots than other blood sources, which can interfere with, or preclude, sample analysis. Cord blood samples are irreplaceable and cannot be recollected, thereby compromising clinical decision-making when analysis is not possible. We evaluated processes to prevent excessive rates of cord blood clotting and quantified their impact on successful testing of blood gas specimens. Methods: Verified result and cancellation data were obtained retrospectively from the laboratory information system. Clot catchers were evaluated using noncord remnant specimens. Collection syringes were compared via collection from remnant cord sections. Results: Prior to implementation of any interventions, retrospective analysis indicated a cancellation rate of 18.6% for umbilical cord blood gas specimens (arterial and venous) and 0.7% for noncord blood arterial and venous samples. Clot catchers were validated for clinical use, with a bias of <±4% for all analytes. After clot catchers were implemented for all cord specimens, cancellation rate decreased approximately 5-fold in the first month and remained <5% a year after implementation. A limited comparison of two heparin syringe types revealed a small difference in the overall rate of specimen clotting. Conclusions: Implementation of clot catchers was acceptable for analysis of cord blood samples, and when implemented resulted in a sustained 5-fold decrease in the rate of cord blood gas order cancellation.